c.inglethorpe
TL3 Regular · Zürich, CH
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 18 January 2025 · last posted 1d · groups: pharmacists
2 replies marked as the accepted answer.
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #8 · marked as the solution · Compounds › Tirzepatide · 14 Sep 2025 · 24 likes post #7 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
How to ask for a dose change without antagonising anyone Replied, post #8 · marked as the solution · Clinical › Prescriber conversations · 24 Jul 2024 · 22 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.